IKBKB and colorectal adenocarcinoma: Finally, we used CRISPR–Cas9 gene editing to generate clones lacking IKKα or IKKβ in a second, independent colorectal adenocarcinoma cell line, SW620, isolated from a metastatic site in the lymph node of a 51 year old Caucasian male.